Modulation of the nitric oxide synthase pathway in atherosclerosis

Experimental Physiology

Volumn 83, Issue 5, 1998, Pages 573-584

  Maxwell, Andrew J ^b   Tsao, Philip S ^a   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Integrative Medical Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ARGININE; CHOLESTEROL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; ENZYME REGULATION; HUMAN; REVIEW; RISK FACTOR; SMOKING; VASCULAR ENDOTHELIUM;

EID: 0031720177     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/expphysiol.1998.sp004139     Document Type: Review

References (83)

1. AJI, W., RAVALLI, S., SZABOLCS, M., JIANG, X. C., SCIACCA, R. R., MICHLER, R. E. & CANNON, P. J. (1997). L-Arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation 95, 430-437.
2. ANDERSON, T. J., MEREDITH, I. T., YEUNG, A. C., FREI, B., SELWYN, A. P. & GANZ, P. (1995). The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. New England Journal of Medicine 322, 488-493.
3. BARRETT-CONNOR, E. L., COHN, B. A., WINGARD, D. L. & EDELSTEIN, S. L. (1991). Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. Journal of the American Medical Association 265, 627-631.
4. BIERHAUS, A., CHEVION, S., CHEVION, M., HOFMANN, M., QUEHENBERGER, P., ILLMER, T., LUTHER, T., BERENTSHTEIN, E., TRITSCHLER, H., MULLER, M., WAHL, P., ZIEGLER, R. & NAWROTH, P. P. (1997). Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 46, 1481-1490.
5. BÖGER, R. H., BODE-BÖGER, S. M., BRANDES, R. P., PHIVTHONG-NGAM, L., BOHME, M., NAFE, R., MUGGE, A. & FRÖLICH, J. C. (1997a). Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation 96, 1282-1290.
6. BÖGER, R. H., BODE-BÖGER, S. M., SZUBA, A., TSAO, P. S., CHAN, J. R. & COOKE, J. P. (1997b). Asymmetric dimethylarginine: A new risk factor for endothelial dysfunction. Circulation 96, I-32.
7. BÖGER, R. H., BODE-BÖGER, S. M., THIELE, W., JUNKER, W., ALEXANDER, K. & FROLICH, J. C. (1997c). Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95, 2068-2074.
8. CANDIPAN, R. C., WANG, B. Y., BUITRAGO, R., TSAO, P. S. & COOKE, J. P. (1996). Regression or progression. Dependency on vascular nitric oxide. Arteriosclerosis and Thrombosis in Vascular Biology 16, 44-50.
9. CELERMAJER, D. S., SORENSEN, K. E., GEORGAKOPOULOS, D., BULL, C., THOMAS, O., ROBINSON, J. & DEANFIELD, J. E. (1993). Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88, 2149-2155.
10. CHIBBER, R., MOLINATTI, P. A., ROSATTO, N., LAMBOURNE, B. & KOHNER, E. M. (1997). Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia 40, 156-164.
11. CLANCY, R. M., LESZCZYNSKA, P., PIZIAK, J. & ABRAMSON, S. B. (1992). Nitric oxide, an endothelial cell relation factor, inhibits neutrophil superoxide anion production via a direct action on NADPH oxidase. Journal of Clinical Investigation 90, 1116-1121.
12. CLARKSON, P., ADAMS, M. R., POWE, A. J., DONALD, A. E., MCCREDIE, R., ROBINSON, J., MCCARTHY, S. N., KEECH, A., CELERMAJER, D. S. & DEANFIELD, J. E. (1996a). Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. Journal of Clinical Investigation 97, 1989-1994.
13. CLARKSON, P., CELERMAJER, D. S., DONALD, A. E., SAMPSON, M., SORENSEN, K. E., ADAMS, M., YUE, D. K., BETTERIDGE, D. J. & DEANFIELD, J. E. (1996b). Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. Journal of the American College of Cardiology 28, 573-579.
14. COOKE, J. P., DZAU, J. & CREAGER, A. (1991). Endothelial dysfunction in hypercholesterolemia is corrected by L-arginine. Basic Research in Cardiology 86, suppl. 2, 173-181.
15. COOKE, J. P., SINGER, A. H., TSAO, P., ZERA, P., ROWAN, R. A. & BILLINGHAM, M. E. (1992). Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. Journal of Clinical Investigation 90, 1168-1172.
16. COSENTINO, F. & KATUSIC, Z. S. (1995). Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91, 139-144.
17. CYBULSKY, M. I. & GIMBRONE, M. A. JR (1991). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791.
18. DECATERINA, R., LIBBY, P., PENG, H.-B., THANNICKAL, V. J., RAJAVASHISTH, T. B., GIMBRONE, M. A. J., SHIN, W. S. & LIAO, J. K. (1995). Nitric oxide decreases cytokine-induced endothelial activation. Journal of Clinical Investigation 96, 60-68.
19. EGASHIRA, K., SUZUKI, S., HIROOKA, Y., KAI, H., SUGIMACHI, M., IMAIZUMI, T. & TAKESHITA, A. (1995). Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25, 201-206.
20. FARACI, F. M., BRIAN, J. E. JR & HEISTAD, D. D. (1995). Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. American Journal of Physiology 269, H1522-1527.
21. G dimethylarginine by human endothelial cells. Endothelium 1, 137-140.
22. FUSTER, V., GOTTO, A. M., LIBBY, P., LOSCALZO, J. & MCGILL, H. C. (1996). 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors. Journal of the American College of Cardiology 27, 964-976.
23. GARG, U. C. & HASSID, A. (1989). Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation 83, 1774-1777.
24. GARG, U. C. & HASSID, A. (1990). Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism. Biochemical and Biophysical Research Communications 171, 474-479.
25. GIRERD, X. J., HIRSCH, A. T., COOKE, J. P., DZAU, V. J. & CREAGER, M. A. (1990). L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circulation Research 67, 1301-1308.
26. GRISHAM, M. B. & MCCORD, J. (1986). Chemistry and cytotoxicity of reactive oxygen metabolites. In Physiology of Oxygen Radicals, ed. TAYLOR, A. E., MATALON, S. & WARD, P., pp. 1-18. American Physiological Society, Bethesda.
27. HARKER, L. A., ROSS, R., SLIGHTER, S. J. & SCOTT, C. R. (1976). Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. Journal of Clinical Investigation 58, 731-741.
28. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochemical Journal 281, 627-630.
29. HOGG, N., KALYANARAMAN, B., JOSEPH, J., STRUCK, A. & PARTHASARATHY, S. (1993). Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Letters 334, 170-174.
30. HORNIG, B., ARAKAWA, N., SMOLARSKI, R., SCHIEFFER, B. & DREXLER, H. (1997). Concomitant enhancement of NO-mediated vasodilation and pro-fibrinolytic activity by ACE-inhibition in patients with coronary artery disease. Circulation 96, I-114.
31. HUK, I., NANOBASHVILI, J., NEUMAYER, C., PUNZ, A., MUELLER, M., AFKHAMPOUR, K., MITTLBOECK, M., LOSERT, U., POLTERAUER, P., ROTH, E., PATTON, S. & MALINSKI, T. (1997). L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 96, 667-675.
32. KILO, C. (1997). Metformin: a safe and effective treatment in the management of NIDDM. Molecular Medicine 94, 114-123.
33. LIN, K. T., XUE, J. Y., NOMEN, M., SPUR, B. & WONG, P. Y. (1995). Peroxynitrite-induced apoptosis in HL-60 cells. Journal of Biological Chemistry 270, 16487-16490.
34. LÜSCHER, T. F., RAIJ, L. & VANHOUTTE, P. M. (1987). Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 9, 157-163.
35. MACALLISTER, R. J., FICKLING, S. A., WHITLEY, G. S. & VALLANCE, P. (1994). Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. British Journal of Pharmacology 112, 43-48.
36. MACALLISTER, R. J., PARRY, H., KIMOTO, M., OGAWA, T., RUSSELL, R. J., HUDSON, H., WHITLEY, G. S. J. & VALLANCE, P. (1996). Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. British Journal of Pharmacology 119, 1-8.
37. MCCULLY, K. S. & WILSON, R. B. (1975). Homocysteine theory of arteriosclerosis. Atherosclerosis 22, 215-227.
38. MCLENACHAN, J. M., WILLIAMS, J. K., FISH, R. D., GANZ, P. & SELWYN, A. P. (1991). Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation 84, 1273-1278.
39. MARFELLA, R., ACAMPORA, R., VERRAZZO, G., ZICCARDI, P., DE ROSA, N., GIUNTA, R. & GIUGLIANO, D. (1996). Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients. Diabetes Care 19, 934-939.
40. MARUI, N., OFFERMANN, M. K., SWERLICK, R., KUNSCH, C., ROSEN, C. A., AHMAD, M., ALEXANDER, R. W. & MEDFORD, R. M. (1993). Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. Journal of Clinical Investigation 92, 1866-1874.
41. MAYER, B., JOHN, M., HEINZEL, B., WERNER, E. R., WACHTER, H., SCHULTZ, G. & BOHME, E. (1991). Brain nitric oxide synthase is a biopterin-and flavin-containing multi-functional oxido-reductase. FEBS Letters 288, 187-191.
42. MILLER, V. M. & BURNETT, J. C. JR (1992). Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. American Journal Physiology 263, H103-108.
43. MORANO, M. A. (1996). Current estimates from the National Health Interview Survey, 1994. In DHHS publication PHS 96-1521, (N. C. f. H. Statistics, ed.), vol. 193. US Government Printing Office, Washington DC.
44. MOTULSKY, A. G. (1996). Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. American Journal of Genetics 58, 17-20.
45. NATIONAL CENTER FOR HEALTH STATISTICS (1994). Annual summary of births, marriages, divorces and deaths, United States 1994. Monthly Vital Statistics Report 1995 43, 13.
46. NIEBAUER, J. & COOKE, J. P. (1996). Cardiovascular effects of exercise: role of endothelial shear stress. Journal of the American College of Cardiology 28, 1652-1660.
47. NIEBAUER, J., MAXWELL, A. J., LIN, P. S., TSAO, P. S., KOSEK, J., BERNSTEIN, D. & COOKE, J. P. (1998). Hypercholesterolemia impairs aerobic adaptations to chronic exercise training. American Journal of Physiology (in the Press).
48. OCKENE, J. K., KULLER, L. H., SVENDSEN, K. H. & MEILAHN, E. (1990). The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). American Journal of Public Health 80, 954-958.
49. OHARA, Y., PETERSEN, T. E. & HARRISON, D. G. (1993). Hypercholesterolemia increases endothelial superoxide anion production. Journal of Clinical Investigation 91, 2546-2551.
50. PANZA, J. A., CASINO, P. R., KILCOYNE, C. M. & QUYYUMI, A. A. (1994). Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. Journal of the American College of Cardiology 23, 1610-1616.
51. PASTERNAK, R. C., GRUNDY, S. M., LEVY, D. & THOMPSON, P. D. (1996). 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 3. Spectrum of risk factors for coronary heart disease. Journal of the American College of Cardiology 27, 978-990.
52. PENG, H. B., LIBBY, P. & LIAO, J. K. (1995). Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. Journal of Biological Chemistry 270, 14214-14219.
53. POLLOCK, J. S., FORSTERMANN, U., MITCHELL, J. A., WARNER, T. D., SCHMIDT, H. H., NAKANE, M. & MURAD, F. (1991). Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proceedings of the National Academy of Sciences of the USA 88, 10480-10484.
54. PRITCHARD, K. A. JR, GROSZEK, L., SMALLEY, D. M., SESSA, W. C., WU, M., VILLALON, P., WOLIN, M. S. & STEMERMAN, M. B. (1995). Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circulation Research 77, 510-518.
55. RADI, R., BECKMAN, J. S., BUSH, K. M. & FREEMAN, B. A. (1991). Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. Journal of Biological Chemistry 266, 4244-4250.
56. RAJAGOPALAN, S., KURZ, S., MUNZEL, T., TARPEY, M., FREEMAN, B. A., GRIENDLING, K. K. & HARRISON, D. G. (1996). Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. Journal of Clinical Investigation 97, 1916-1923.
57. RAWAL, N., RAJPUROHIT, R., LISCHWE, M. A., WILLIAMS, K. R., PAIK, W. K. & KIM, S. (1995). Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltransferases. Biochimica et Biophysica Acta 1248, 11-18.
58. ROSENBERG, L., KAUFMAN, D. W., HELMRICH, S. P. & SHAPIRO, S. (1985). The risk of myocardial infarction after quitting smoking in men under 55 years of age. New England Journal of Medicine 313, 1511-1514.
59. ROSS, R. (1997). Cellular and molecular studies of atherogenesis. Atherosclerosis 131, suppl., S3-4.
60. SACKS, F. M., PFEFFER, M. A., MOYE, L. A., ROULEAU, J. L., RUTHERFORD, J. D., COLE, T. G., BROWN, L., WARNICA, J. W., ARNOLD, J. M., WUN, C. C., DAVIS, B. R. & BRAUNWALD, E. (1996). The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. New England Journal of Medicine 335, 1001-1009.
61. SCHAFFNER, A., BLAU, N., SCHNEEMANN, M., STEURER, J., EDGELL, C. J. & SCHOEDON, G. (1994). Tetrahydrobiopterin as another EDRF in man. Biochemical and Biophysical Research Communications 205, 516-523.
62. SCHMIDT, A. M., HORI, O., CAO, R., YAN, S. D., BRETT, J., WAUTIER, J. L., OGAWA, S., KUWABARA, K., MATSUMOTO, M. & STERN, D. (1996). RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45, suppl. 3, S77-80.
63. SESSA, W. C., PRITCHARD, K., SEYEDI, N., WANG, J. & HINTZE, T. H. (1994). Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide sythase gene expression. Circulation Research 74, 349-353.
64. SHIMOKAWA, H., LAWRENCE, L. A. & VANHOUTTE, P. M. (1987). Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circulation Research 61, 256-269.
65. STAMLER, J. S., OSBORNE, J. A., JARAKI, O., RABBANI, L. E., MULLINS, M., SINGEL, D. & LOSCALZO, J. (1993). Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. Journal of Clinical Investigation 91, 308-318.
66. STAMLER, J. S., SIMON, D. I., OSBORNE, J. A., MULLINS, M., JARAKI, O., MICHEL, T., SINGEL, D. & LOSCALZO, J. (1992). S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proceedings of the National Academy of Sciences of the USA 89, 444-448.
67. STARKEBAUM, G. & HARLAN, J. M. (1986). Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. Journal of Clinical Investigation 77, 1370-1376.
68. STROES, E., KASTELEIN, J., COSENTINO, F., ERKELENS, W., WEVER, R., KOOMANS, H., LUSCHER, T. & RABELINK, T. (1997). Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. Journal of Clinical Investigation 99, 41-46.
69. STROES, E. S., KOOMANS, H. A., DE BRUIN, T. W. & RABELINK, T. J. (1995). Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 346, 467-471.
70. TREASURE, C. B., KLEIN, J. L., WEINTRAUB, W. S., TALLEY, J. D., STILLABOWER, M. E., KOSINSKI, A. S., ZHANG, J., BOCCUZZI, S. J., CEDARHOLM, J. C. & ALEXANDER, R. W. (1995). Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. New England Journal of Medicine 332, 481-487.
71. TSAO, P. S., BUITRAGO, R., CHAN, J. R. & COOKE, J. P. (1996). Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. Circulation 94, 1682-1689.
72. TSAO, P. S., LEWIS, N. P. & COOKE, J. P. (1995). Exposure to shear stress alters endothelial adhesiveness: Role of nitric oxide. Circulation 92, 3513-3519.
73. TSAO, P. S., WANG, B., BUITRAGO, R., SHYY, J. Y. & COOKE, J. P. (1997). Nitric oxide regulates monocyte chemotactic protein-1. Circulation 96, 934-940.
74. VALLANCE, P., LEONE, A., CALVER, A., COLLIER, J. & MONCADA, S. (1992). Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. Journal of Cardiovascular Pharmacology 20, suppl. 12, S60-62.
75. VAN DEN BERG, M., BOERS, G. H., FRANKEN, D. G., BLOM, H. J., VAN KAMP, G. J., JAKOBS, C., RAUWERDA, J. A., KLUFT, C. & STEHOUWERT, C. D. (1995). Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. European Journal of Clinical Investigation 25, 176-181.
76. VLASSARA, H. (1996). Advanced glycation end-products and atherosclerosis. Annals of Internal Medicine 28, 419-426.
77. WANG, B., LIN, P. S., TSAO, P. S. & COOKE, J. P. (1996). Nitric oxide induces regression: Role of apoptosis. Circulation 94, A900.
78. WANG, B. Y., SINGER, A. H., TSAO, P. S., DREXLER, H., KOSEK, J. & COOKE, J. P. (1994). Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. Journal of the American College of Cardiology 23, 452-458.
79. WATTS, G. F., O'BRIEN, S. F., SILVESTER, W. & MILLAR, J. A. (1996). Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clinical Science (Colch) 91, 567-573.
80. WEIDINGER, F., MCLENACHAN, J. M., CYBULSKY, M. I., GORDON, J. B., RENNKE, H. G., HOLLENBERG, N. K., FALLON, J. T., GANZ, P. & COOKE, J. P. (1990). Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation 81, 1667-1679.
81. WOLF, A., ZALPOUR, C., THEILMEIER, G., WANG, B. Y., MA, A., ANDERSON, B., TSAO, P. S. & COOKE, J. P. (1997). Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. Journal of the American College of Cardiology 29, 479-485.
82. WU, G. & MEININGER, C. J. (1995). Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat. American Journal of Physiology 269, H1312-1318.
83. ZEIHER, A. M., FISSLTHALER, B., SCHRAY-UTZ, B. & BUSSE, R. (1995). Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circulation Research 76, 980-986.